about
Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugatesGlutathione-Responsive Selenosulfide Prodrugs as a Platform Strategy for Potent and Selective Mechanism-Based Inhibition of Protein Tyrosine Phosphatases.Site-Specific Antibody Conjugation for ADC and Beyond.Diphthamide affects selenoprotein expression: Diphthamide deficiency reduces selenocysteine incorporation, decreases selenite sensitivity and pre-disposes to oxidative stress
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Stable and Potent Selenomab-Drug Conjugates.
@en
type
label
Stable and Potent Selenomab-Drug Conjugates.
@en
prefLabel
Stable and Potent Selenomab-Drug Conjugates.
@en
P2093
P2860
P1476
Stable and Potent Selenomab-Drug Conjugates
@en
P2093
Alex R Nanna
Christopher G Nelson
David Hymel
Lori Hazlehurst
Pablo Martinez-Acedo
Rajesh R Nair
Terrence R Burke
Tina Moroni
Xiuling Li
P2860
P304
433-442.e6
P356
10.1016/J.CHEMBIOL.2017.02.012
P577
2017-03-16T00:00:00Z